Prices delayed by at least 15 minutes | Print
Shockwave Medical (SWAV)
Common SharesOpen
$330.1
Previous close
$330
Trade high
$331
Volume
810,028
Year high
$331.58
Year low
$157.00
Dividend yield
-
Market capitalisation
$12.39 bn
P/E ratio
85.71
ISIN
US82489T1043
This share can be held in a Dealing accountISALifetime ISAJISASIPP
Share price
Company profile
Shockwave Medical Inc is a medical device company focused on developing and commercializing novel technologies that transform the care of patients with cardiovascular disease. It establishes a new standard of care for the treatment of calcified cardiovascular disease ("atherosclerosis") through differentiated and proprietary local delivery of sonic pressure waves, which refer to as intravascular lithotripsy ("IVL"). Its IVL technology is a minimally invasive, easy-to-use, and safe way to improve outcomes for patients with calcified cardiovascular disease also IVL catheters enables delivery of IVL therapy to diseased vasculature throughout the body for calcium modification.
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.